| DNA replication |
2.05 |
0.00e+0 |
34/36 (94.44%) |
POLE2;RFC3;DNA2;...
|
| Fanconi anemia pathway |
1.97 |
5.15e-3 |
36/54 (66.67%) |
FANCL;CENPX;RMI1;...
|
| Pyrimidine metabolism |
1.78 |
3.43e-2 |
40/56 (71.43%) |
DCK;UMPS;DCTPP1;...
|
| Homologous recombination |
1.78 |
2.58e-2 |
35/41 (85.37%) |
RAD54B;TOPBP1;RAD51;...
|
| Mismatch repair |
1.76 |
2.47e-2 |
22/23 (95.65%) |
RFC3;MSH2;MSH6;...
|
| Pentose and glucuronate interconversions |
1.74 |
2.58e-2 |
17/34 (50%) |
UGT2B28;CRYL1;SORD;...
|
| Drug metabolism |
1.72 |
2.50e-2 |
78/151 (51.66%) |
UGT2B28;FMO2;MGST3;...
|
| Base excision repair |
1.69 |
3.48e-2 |
29/33 (87.88%) |
POLE2;FEN1;NEIL3;...
|
| Ascorbate and aldarate metabolism |
1.67 |
3.61e-2 |
15/30 (50%) |
UGT2B28;ALDH3A2;UGDH;...
|
| Glycosaminoglycan degradation |
-1.67 |
2.12e-2 |
19/19 (100%) |
IDS;HEXB;HGSNAT;...
|
| Protein processing in endoplasmic reticulum |
-1.68 |
2.14e-2 |
127/171 (74.27%) |
HERPUD1;SEC24A;SSR2;...
|
| Proteoglycans in cancer |
-1.68 |
2.16e-2 |
172/205 (83.9%) |
COL1A1;KDR;IQGAP1;...
|
| Focal adhesion |
-1.72 |
1.82e-2 |
180/201 (89.55%) |
COL1A1;KDR;COL9A1;...
|
| Central carbon metabolism in cancer |
-1.73 |
1.66e-2 |
67/70 (95.71%) |
GLS;TIGAR;MAP2K1;...
|
| MAPK signaling pathway |
-1.73 |
1.66e-2 |
272/294 (92.52%) |
DUSP6;RASGRP3;STK4;...
|
| PI3K-Akt signaling pathway |
-1.73 |
1.73e-2 |
317/354 (89.55%) |
RELA;PIK3R2;LAMA2;...
|
| Non-small cell lung cancer |
-1.75 |
1.29e-2 |
70/72 (97.22%) |
KIF5C;PIK3R2;MAPK1;...
|
| Notch signaling pathway |
-1.75 |
1.35e-2 |
49/59 (83.05%) |
EP300;ADAM17;ATXN1;...
|
| Parathyroid hormone synthesis, secretion and action |
-1.75 |
1.42e-2 |
98/106 (92.45%) |
MMP13;CREB3;PDE4C;...
|
| Glioma |
-1.77 |
1.49e-2 |
67/75 (89.33%) |
CAMK1D;CDKN2A;MAP2K1;...
|
| Glyoxylate and dicarboxylate metabolism |
-1.77 |
1.25e-2 |
23/30 (76.67%) |
AGXT;CAT;ACO2;...
|
| Pancreatic cancer |
-1.79 |
1.07e-2 |
75/76 (98.68%) |
TGFBR2;RELA;PIK3R2;...
|
| Relaxin signaling pathway |
-1.79 |
1.14e-2 |
114/129 (88.37%) |
FOS;COL1A1;RLN1;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
-1.80 |
1.02e-2 |
62/70 (88.57%) |
ATP6V0C;MAPK11;RELA;...
|
| Lysosome |
-1.81 |
9.91e-3 |
115/128 (89.84%) |
DNASE2;CTSF;SLC11A1;...
|
| Rheumatoid arthritis |
-1.81 |
8.49e-3 |
78/93 (83.87%) |
ICAM1;ATP6V1F;ATP6V1E1;...
|
| Bladder cancer |
-1.82 |
8.00e-3 |
40/41 (97.56%) |
MAPK1;MDM2;TYMP;...
|
| Chronic myeloid leukemia |
-1.83 |
8.67e-3 |
72/76 (94.74%) |
TGFBR2;RELA;PIK3R2;...
|
| AGE-RAGE signaling pathway in diabetic complications |
-1.84 |
6.75e-3 |
97/100 (97%) |
COL1A1;SERPINE1;TGFBR2;...
|
| Arginine biosynthesis |
-1.86 |
7.43e-3 |
17/22 (77.27%) |
GLS;GLUD2;ASL;...
|
| Phagosome |
-1.87 |
4.95e-3 |
118/152 (77.63%) |
ATP6V1F;ATP6V1E1;ITGB1;...
|
| Amoebiasis |
-1.88 |
3.71e-3 |
99/102 (97.06%) |
IL1R1;COL1A1;ACTN4;...
|
| Human papillomavirus infection |
-1.90 |
4.25e-3 |
284/331 (85.8%) |
NOTCH4;COL1A1;TCF7L2;...
|
| Steroid biosynthesis |
-1.91 |
4.95e-3 |
19/20 (95%) |
LSS;CYP51A1;FDFT1;...
|
| Hepatocellular carcinoma |
-1.92 |
5.94e-3 |
135/168 (80.36%) |
CDKN2A;SMARCD3;PBRM1;...
|
| Mitophagy |
-1.93 |
7.43e-3 |
56/68 (82.35%) |
SQSTM1;SRC;TP53;...
|
| Vibrio cholerae infection |
-1.96 |
4.95e-3 |
44/50 (88%) |
PDIA4;ATP6V0C;PRKACA;...
|
| ECM-receptor interaction |
-1.97 |
7.43e-3 |
80/88 (90.91%) |
COL1A1;COL9A1;ITGB6;...
|
| Protein digestion and absorption |
-2.30 |
0.00e+0 |
78/103 (75.73%) |
MME;COL4A1;COL3A1;...
|
